Sleep Disorders

The NeurologyLive clinical focus page on sleep disorders provides information about the latest FDA actions, clinical guideline updates, clinical trial findings, and interviews with physicians on conditions such as obstructive sleep apnea, cataplexy, narcolepsy, insomnia, excessive daytime sleepiness, and more. The page features podcasts, videos, and news stories about the latest in clinical care for these sleep disorders.

Episode 59: AASM's Push to End Daylight Saving Time

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Seema Khosla, MD, FCCP, FAASM.

Unmet Needs in Treating Insomnia

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

NeuroVoices: Christian Agudelo, MD, on Sleep’s Impact on Cognitive Decline

The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine detailed his study on the correlations between sleep and cognitive decline in middle-aged Hispanics.

FDA Action Update, September 2022: Holds Lifted, Applications, and Approvals

October 04, 2022

Article

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

Nonpharmacologic Interventions Improve Sleep Time in Hospitalized Patients

October 03, 2022

Article

Findings from a nonrandomized controlled trial in the Netherlands suggest that sleep time of hospitalized patients may be significantly improved with nonpharmacologic interventions such as the postponement of morning vital sign checks and medication administration rounds from the night to the day shift.

This Week on NeurologyLive® — October 3, 2022

October 03, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

NeurologyLive® Brain Games: October 2, 2022

October 02, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is general neurology, related to the recent 4th Annual International Congress on the Future of Neurology®.

NeurologyLive® Friday 5 — September 30, 2022

September 30, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.

Electroacupuncture for Insomnia Significantly Improves Quality of Sleep in Patients With Depression

September 30, 2022

Article

In a randomized clinical trial, the application of electroacupuncture treatment for insomnia in patients with depression significantly improved the quality of sleep in comparison with sham acupuncture or the control group.

Acupuncture Proves Effective as Method to Improve Sleep Quality for Post-Stroke Insomnia

September 27, 2022

Article

In a randomized controlled trial, results demonstrated that acupuncture is to be efficacious in improving insomnia, quality of life, and affective symptoms for patients with ischemic stroke.

This Week on NeurologyLive® — September 26, 2022

September 26, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

NeurologyLive® Brain Games: September 25, 2022

September 25, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of the American Association of Neuromuscular & Electrodiagnostic Medicine.

NeurologyLive® Friday 5 — September 23, 2022

September 23, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 23, 2022.

Latest News

Crenezumab Does Not Reduce Clinical Decline in Adults With Early Alzheimer Disease

Advancing the Treatment Paradigm for Myasthenia Gravis and Looking Toward the Future

Institutional Perspectives in Neurology, Chaired by Riley Bove, MD

Majority of Canadian Physicians Treat Primary Headache Disorders With Nonsteroidal Anti-inflammatory Drugs, Dopamine Receptor Antagonists

View More News